School of Biomedical Engineering, University of British Columbia, Vancouver, BC, Canada.
Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
Front Immunol. 2022 Aug 16;13:946905. doi: 10.3389/fimmu.2022.946905. eCollection 2022.
Innate lymphoid cells (ILCs) are frontline immune effectors involved in the early stages of host defense and maintenance of tissue homeostasis, particularly at mucosal surfaces such as the intestine, lung, and skin. Canonical ILCs are described as tissue-resident cells that populate peripheral tissues early in life and respond appropriately based on environmental exposure and their anatomical niche and tissue microenvironment. Intriguingly, there are accumulating reports of ILC "plasticity" that note the existence of non-canonical ILCs that exhibit distinct patterns of master transcription factor expression and cytokine production profiles in response to tissue inflammation. Yet this concept of ILC-plasticity is controversial due to several confounding caveats that include, among others, the independent large-scale recruitment of new ILC subsets from distal sites and the local, in situ, differentiation of uncommitted resident precursors. Nevertheless, the ability of ILCs to acquire unique characteristics and adapt to local environmental cues is an attractive paradigm because it would enable the rapid adaptation of innate responses to a wider array of pathogens even in the absence of pre-existing 'prototypical' ILC responder subsets. Despite the impressive recent progress in understanding ILC biology, the true contribution of ILC plasticity to tissue homeostasis and disease and how it is regulated remains obscure. Here, we detail current methodologies used to study ILC plasticity in mice and review the mechanisms that drive and regulate functional ILC plasticity in response to polarizing signals in their microenvironment and different cytokine milieus. Finally, we discuss the physiological relevance of ILC plasticity and its implications for potential therapeutics and treatments.
先天淋巴细胞(ILCs)是参与宿主防御和组织稳态维持的一线免疫效应细胞,尤其在肠道、肺和皮肤等黏膜表面。经典的 ILC 被描述为组织驻留细胞,它们在生命早期就存在于外周组织中,并根据环境暴露及其解剖部位和组织微环境做出适当的反应。有趣的是,越来越多的关于 ILC“可塑性”的报道指出,存在非经典的 ILC,它们在组织炎症时表现出不同的主转录因子表达模式和细胞因子产生谱。然而,由于存在几个混杂的注意事项,包括其他的,如从远处部位独立地大规模募集新的 ILC 亚群,以及未分化的常驻前体的局部原位分化,因此 ILC 可塑性的概念存在争议。尽管 ILC 获得独特特征并适应局部环境线索的能力是一个有吸引力的范例,因为它可以使先天反应在没有预先存在的“典型”ILC 应答亚群的情况下,快速适应更广泛的病原体,但 ILC 可塑性对组织稳态和疾病的真正贡献以及它是如何被调控的仍然不清楚。在这里,我们详细介绍了目前用于研究小鼠 ILC 可塑性的方法,并综述了驱动和调节功能性 ILC 可塑性的机制,以响应其微环境中的极化信号和不同的细胞因子环境。最后,我们讨论了 ILC 可塑性的生理相关性及其对潜在治疗和治疗的意义。